CA08.0ICD-11 MMS 2026-01
Allergic rhinitis
Description
Allergic rhinitis is an inflammation of nasal airway triggered by allergens to which the affected individual has previously been sensitized. Pathogenesis of allergic rhinitis is type I allergy on the nasal mucosa. Antigens inhaled into sensitized nasal mucosa bind to IgE antibodies on mast cells, which release chemical mediators such as histamine and peptide leukotriene. Consequently terminal of sensory neurons and vessels react to induce sneezing, running nose, and stuffy nose (immediate phase reaction). In late phase reaction, various chemical mediators are produced by mast cells, cytokines are produced by Th2 and mast cells, and chemokines are produced by epithelial cells, endothelium of blood vessels, and fibrocytes, respectively. These cell-derived transmitters actually induce various cell types of inflammatory cell infiltration to nasal mucosa. Among them, activated eosinophils is the main player of mucosal swelling and hyperreactivity.
Exclusions from above levels
CA09.0– rhinitis NOSCA22.0– Chronic obstructive pulmonary disease with acute exacerbation, unspecified01– Certain infectious or parasitic diseases
Show allHide
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium19– Certain conditions originating in the perinatal period20– Congenital malformations, deformations and chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes
Child codes
Sibling codes
Foundation entity
Part of: CA08: Vasomotor or allergic rhinitis › 12: Diseases of the respiratory system